Avance Clinical News

  1. Avance Clinical At World Vaccine Congress To Share Latest Vaccine Clinical Trial News Including An HIV-1 Study 5/3/2024

    Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend World Vaccine Congress in Washington DC (April 1-4, 2024) and share the latest clinical trial client news including the Uvax Bio announcement.

  2. Introducing William Faria, The New Vice President Of Biometrics At Avance Clinical 4/16/2024

    Avance Clinical, the Australian and North American market-leading Contract Research Organization (CRO) for biotechs, proudly welcomes William Faria as its new Vice President of Biometrics

  3. Avance Clinical CEO Talks With SCRIP Intelligence About A New CRO Report And US Biotech Sector 'Green Shoots' 3/4/2024

    Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, has today spoken with SCRIP Intelligence about their positive outlook for the US biotech sector following the J.P. Morgan Healthcare Conference and Biotech Showcase meetings.

  4. Avance Clinical And Ryght Partner To Bring Novel GenAI Technologies To Clinical Research Networks 2/22/2024

    Ryght, an innovator in generative artificial intelligence (GenAI) technology for the Life Science industry, today announced a strategic partnership with Avance Clinical, the largest specialist Australian and US CRO (Clinical Research Organization) delivering quality clinical trials in Australia, New Zealand and North America for international biopharma companies.

  5. Frost & Sullivan Analysis Reveals 65% Of US Biotechs Struggle To Identify Suitable CRO Partner 1/8/2024

    Avance Clinical, the leading Australian and North American CRO for biotechs announced today that new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug development program.